NEW York (GenomeWeb News) – Gen-Probe and 3M said after the close of the market on Monday that they have disbanded their collaboration to develop molecular diagnostic tests for healthcare-associated infections.

 

The firms had been evaluating whether they could combine Gen-Probe’s nucleic acid testing technologies with 3M’s microfluidics instrument platform but found the technologies to be technically incompatible.